Filing Details

Accession Number:
0001640334-19-001052
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-06-05 16:31:10
Reporting Period:
2019-06-03
Accepted Time:
2019-06-05 16:31:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1711754 Inmune Bio Inc. INMB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1289624 F Linda Powers C/O Inmune Bio Inc.
1224 Prospect Street, Suite 150
La Jolla CA 92037
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-06-03 10,000 $6.00 1,130,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Includes 10,000 shares of the Issuer's common stock acquired by the Reporting Person in connection with a private sale by a and among a holder of the registrant's common stock, the Reporting Person, and certain other accredited investors.
  2. Includes (i) 700,000 shares held by Toucan Capital Fund III, LP and (ii) 430,000 shares held by Linda F. Powers ("Powers"). Toucan Capital III, LP is managed by Powers. Powers holds all voting and dispositive power over the shares of common stock held by Toucan Capital Fund III, LP.